Evaluation of Vitek2 and BD Phoenix in antimicrobial susceptibility testing of Acinetobacter baumannii and Pseudomonas aeruginosa

Dong Wook Jekarl; Sang Bong Han; Yoon Joo Kim; Sang Hyun Shin; Kang Gyun Park; Jung Jun Park; Kyungja Han; Yeon-Joon Park

doi:10.1016/j.diagmicrobio.2010.02.024

Evaluation of Vitek2 and BD Phoenix in antimicrobial susceptibility testing of Acinetobacter baumannii and Pseudomonas aeruginosa

Diagn Microbiol Infect Dis. 2010 Aug;67(4):384-6. doi: 10.1016/j.diagmicrobio.2010.02.024.

Authors

Dong Wook Jekarl¹, Sang Bong Han, Yoon Joo Kim, Sang Hyun Shin, Kang Gyun Park, Jung Jun Park, Kyungja Han, Yeon-Joon Park

Affiliation

¹ Department of Laboratory Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 137-701, Republic of Korea.

PMID: 20638609
DOI: 10.1016/j.diagmicrobio.2010.02.024

Abstract

The accuracy of antimicrobial susceptibility testing of Vitek2 and BD Phoenix against Acinetobacter baumannii and Pseudomonas aeruginosa was evaluated. Both systems showed overall categoric agreement of < or =90% for cefepime and ceftazidime against A. baumannii and imipenem and cefepime (and ceftazidime with Vitek2) against P. aeruginosa because of high minor error rates.

Publication types

Comparative Study
Evaluation Study

MeSH terms

Acinetobacter baumannii / drug effects*
Anti-Bacterial Agents / pharmacology*
Diagnostic Errors / statistics & numerical data
Humans
Microbial Sensitivity Tests / methods
Pseudomonas aeruginosa / drug effects*

Substances

Anti-Bacterial Agents